To address the need for reliable thrombus exclusion during atrial fibrillation ablation and evaluate the role of intracardiac echocardiography (ICE) compared to traditional methods.
Approach:
Current Guidelines Review: The article reviews the 2023 and 2024 guidelines regarding imaging strategies for thrombus exclusion in atrial fibrillation ablation.
Study Analysis: It discusses a multicenter randomized noninferiority trial demonstrating that ICE is noninferior to transesophageal echocardiography (TEE) for preventing thromboembolic events.
Key Findings:
ICE can detect thrombi in nonappendage locations not seen by TEE.
Patient-reported outcomes favored ICE due to less procedural burden and improved workflow efficiency.
Current guidelines do not provide a clear hierarchy for imaging strategies in thrombus exclusion.
Interpretation:
Limitations:
Current guidelines remain permissive rather than directive regarding imaging strategies.
Continued reliance on TEE may persist due to lack of clear recommendations.
Three of 23 patients experienced heart failure deterioration following medication withdrawal, while adverse drug events occurred only among patients who continued therapy.
